https://wikimd.org/index.php?action=history&feed=atom&title=Ipragliflozin 2026-04-30T05:32:02Z Revision history for this page on the wiki MediaWiki 1.44.2 https://wikimd.org/index.php?title=Ipragliflozin&diff=6311766&oldid=prev 2025-02-18T01:30:05Z

<p>CSV import</p> <table style="background-color: #fff; color: #202122;" data-mw="interface"> <col class="diff-marker" /> <col class="diff-content" /> <col class="diff-marker" /> <col class="diff-content" /> <tr class="diff-title" lang="en"> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">← Older revision</td> <td colspan="2" style="background-color: #fff; color: #202122; text-align: center;">Revision as of 01:30, 18 February 2025</td> </tr><tr><td colspan="2" class="diff-lineno" id="mw-diff-left-l24">Line 24:</td> <td colspan="2" class="diff-lineno">Line 24:</td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><br></td></tr> <tr><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{stub}}</div></td><td class="diff-marker"></td><td style="background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;"><div>{{stub}}</div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;gallery&gt;</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:Ipragliflozin_structure.svg|Chemical structure of Ipragliflozin</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">File:Haworth_projection_of_ipragliflozin.svg|Haworth projection of Ipragliflozin</ins></div></td></tr> <tr><td colspan="2" class="diff-side-deleted"></td><td class="diff-marker" data-marker="+"></td><td style="color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;"><div><ins style="font-weight: bold; text-decoration: none;">&lt;/gallery&gt;</ins></div></td></tr> </table>

Prab https://wikimd.org/index.php?title=Ipragliflozin&diff=5167087&oldid=prev 2024-02-19T22:10:21Z

<p>CSV import</p> <p><b>New page</b></p><div>&#039;&#039;&#039;Ipragliflozin&#039;&#039;&#039; is an [[antidiabetic drug]] that is used in the treatment of [[type 2 diabetes]]. It belongs to the class of drugs known as [[Sodium-glucose transport proteins|SGLT2 inhibitors]], which work by preventing the kidneys from reabsorbing glucose back into the blood, thereby promoting the excretion of glucose in the urine.<br /> <br /> ==Etymology==<br /> The name &quot;Ipragliflozin&quot; is derived from the chemical structure of the drug. The &quot;Ipra-&quot; prefix is derived from the chemical name &quot;Ipragliflozin&quot;, and the &quot;-gliflozin&quot; suffix is common to all drugs in the SGLT2 inhibitor class.<br /> <br /> ==Pharmacology==<br /> Ipragliflozin works by inhibiting the [[Sodium-glucose transport proteins|SGLT2 protein]] in the kidneys. This protein is responsible for reabsorbing glucose from the urine back into the blood. By inhibiting this protein, Ipragliflozin promotes the excretion of glucose in the urine, thereby lowering blood glucose levels.<br /> <br /> ==Clinical Use==<br /> Ipragliflozin is used in the treatment of [[type 2 diabetes]]. It is often used in combination with other antidiabetic drugs, such as [[metformin]], to improve glycemic control in patients who are not adequately controlled on metformin alone.<br /> <br /> ==Side Effects==<br /> Like all drugs, Ipragliflozin can cause side effects. The most common side effects include urinary tract infections, genital infections, and increased urination. Less common but more serious side effects include [[ketoacidosis]], a serious condition that can occur if the body starts to break down fat too quickly.<br /> <br /> ==Related Terms==<br /> * [[Sodium-glucose transport proteins|SGLT2 inhibitors]]<br /> * [[Type 2 diabetes]]<br /> * [[Metformin]]<br /> * [[Ketoacidosis]]<br /> <br /> [[Category:Antidiabetic drugs]]<br /> [[Category:SGLT2 inhibitors]]<br /> [[Category:Type 2 diabetes]]<br /> <br /> {{stub}}</div>

Prab